Evidence map›Paper›PMID 42543382›Full record

ArticleSignal transduction and targeted therapy2026

Targeting the immune-metabolic axis reverses orthodontics-induced systemic pathology.

Yuning Zhang, Shengjie Jiang, Huimin Zheng, Jiacheng Liu, Boon Chin Heng, Weiran Li, Bing Han, Dan Lu, Yan Wei, Xuliang Deng

Abstract read
In one paragraph

Article in Signal transduction and targeted therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuning Zhang *Department of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, PR China.
Shengjie Jiang *Peking University Hospital of Stomatology Sanya Division(Sanya Stomatology Center), Sanya, China.
Huimin Zheng *Peking University Hospital of Stomatology Sanya Division(Sanya Stomatology Center), Sanya, China.
Jiacheng Liu *Department of Geriatric Dentistry, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices & Beijing Key Laboratory of Biomaterials for Oral Disease, Beijing, PR China.
Boon Chin HengDepartment of Geriatric Dentistry, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices & Beijing Key Laboratory of Biomaterials for Oral Disease, Beijing, PR China.
Weiran LiDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, PR China. weiranli@bjmu.edu.cn.ORCID http://orcid.org/0000-0001-9895-1143
Bing HanDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, PR China. kqbinghan@bjmu.edu.cn.
Dan LuDepartment of Immunology, School of Basic Medical Sciences, NHC Key Laboratory of Medical Immunology, Peking University, Beijing, China. taotao@bjmu.edu.cn.ORCID http://orcid.org/0000-0002-3000-5094
Yan WeiPeking University Hospital of Stomatology Sanya Division(Sanya Stomatology Center), Sanya, China. kqweiyan@bjmu.edu.cn.
Xuliang DengPeking University Hospital of Stomatology Sanya Division(Sanya Stomatology Center), Sanya, China. kqdengxuliang@bjmu.edu.cn.ORCID http://orcid.org/0000-0003-1838-6274

Funding

Beijing Nova Program 20250484855National Natural Science Foundation of China (National Science Foundation of China) 52473120National Natural Science Foundation of China (National Science Foundation of China) 81991505National Natural Science Foundation of China (National Science Foundation of China) 82171826National Natural Science Foundation of China (National Science Foundation of China) 82221003National Natural Science Foundation of China (National Science Foundation of China) 82225012National Natural Science Foundation of China (National Science Foundation of China) 82370993National Natural Science Foundation of China (National Science Foundation of China) 82430033National Natural Science Foundation of China (National Science Foundation of China) U22A20160National Natural Science Foundation of China (National Science Foundation of China) U24A20372Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation) L252168
6 · The paper itself

Abstract

Orthodontic treatment corrects various craniofacial malformations primarily through triggering active alveolar bone remodeling, however the potential impacts of this intervention on the systemic immune state have long been insufficiently explored. Here, we show that mechanical force applied during orthodontic treatment can trigger systemic inflammation dominated by adaptive immune responses. This response not only impairs bone repair at distant body sites but also causes temporary liver dysfunction resembling autoimmune conditions characterized by the expansion of CD69⁺ B cells. Mechanistically, IgM produced by these activated B cells acts as a key pathogenic driver of systemic pathology. Inhibiting the activation of local B cells effectively reversed this immunopathology, underscoring the central role of B cell-derived IgM. We also verified that Piezo1⁺ macrophages function as vital mechanosensors, linking orthodontic mechanical stimulation to B cell activation and subsequent IgM release. Multi-organ metabolomic profiling revealed significant amino acid metabolic dysregulation, which further aggravated systemic inflammation. Crucially, supplementation with lysine and alanine alleviated orthodontic treatment-induced inflammation, restored liver function and promoted distal bone repair. Together, these findings uncover an unrecognized systemic immune-metabolic axis during orthodontic therapy and suggest that targeting B cell-IgM responses or metabolic dysregulation may provide therapeutic opportunities to enhance treatment safety and outcomes.

Indexed as

Immunoglobulin MInflammationOrthodonticsAnimalsAntigens, CDAntigens, Differentiation, T-LymphocyteB-LymphocytesCD69 AntigensHumansLectins, C-TypeLymphocyte ActivationMacrophagesMiceAntigens, CDAntigens, Differentiation, T-LymphocyteCD69 AntigensImmunoglobulin MLectins, C-Type

Identifiers

PMID42543382
PMCPMC13429629

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.